In the malignant cytology group (Bethesda category V or VI, n = 78), there were 12 malignant nodules with negative BRAF mutation analysis (10 PTCs and 2 medullary thyroid carcinomas). The gene discussed is BRAF; the disease is medullary thyroid gland carcinoma.